nimodipine has been researched along with Refractory Depression in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lozupone, M | 1 |
| La Montagna, M | 1 |
| D'Urso, F | 1 |
| Piccininni, C | 1 |
| Sardone, R | 1 |
| Dibello, V | 1 |
| Giannelli, G | 1 |
| Solfrizzi, V | 1 |
| Greco, A | 1 |
| Daniele, A | 1 |
| Quaranta, N | 1 |
| Seripa, D | 1 |
| Bellomo, A | 1 |
| Logroscino, G | 1 |
| Panza, F | 1 |
1 review available for nimodipine and Refractory Depression
| Article | Year |
|---|---|
Pharmacotherapy for the treatment of depression in patients with alzheimer's disease: a treatment-resistant depressive disorder.
Topics: Alzheimer Disease; Antipsychotic Agents; Calcium Channel Blockers; Clinical Trials as Topic; Depress | 2018 |